Geneyork Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GENEYORK PHARMS, and what generic and branded alternatives to GENEYORK PHARMS drugs are available?
GENEYORK PHARMS has five approved drugs.
Summary for Geneyork Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Geneyork Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geneyork Pharms | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 211624-001 | Sep 5, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Geneyork Pharms | PREDNISONE | prednisone | TABLET;ORAL | 211496-001 | Dec 28, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Geneyork Pharms | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 214890-002 | Jul 28, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
